INS and type 2 diabetes mellitus: Insulin, a traditional second‐line treatment for type 2 diabetes, leads to sodium and water retention, weight gain and hypoglycaemia, with resultant sympathetic nervous system activation.11, 12 Theoretically, insulin may be detrimental to patients with concomitant HF, but this has yet to be tested in a randomized clinical trial in patients with established HF.